# Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome

> **NCT01051778** · PHASE2 · COMPLETED · sponsor: **Cairo University** · enrollment: 60 (actual)

## Conditions studied

- Recurrent Abortion

## Interventions

- **DRUG:** enoxaparin 40mg plus low dose aspirin
- **DRUG:** Heparin calcium5,000 U twice daily plus low dose aspirin

## Key facts

- **NCT ID:** NCT01051778
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2009-11
- **Final completion:** 2009-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01051778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01051778, "Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT01051778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*